MMP-14

MMP-14 (MT1-MMP, membrane-type 1 matrix metalloproteinase) is a membrane-anchored zinc-dependent endopeptidase that regulates pericellular extracellular matrix (ECM) remodeling by degrading fibrillar collagens, fibronectin, laminins, and other matrix components, thereby controlling cell migration, tissue remodeling, and developmental processes^[5][1]. Mechanistically, MMP-14 functions at the cell surface and is a major activator of proMMP-2 through the well-characterized proMMP-2/TIMP-2/MMP-14 complex, linking localized proteolysis to invasive cellular behavior and matrix turnover^[5][2]. Through direct ECM degradation and activation of additional protease cascades, MMP-14 promotes cellular invasion, angiogenesis, and tissue remodeling in both physiological and pathological settings^[5][1][3]. In disease models, elevated MMP-14 expression is associated with tumor progression, invasion, metastasis, and poor clinical outcome across multiple cancer types, including ovarian carcinoma and other solid tumors^[3][4]. Genetic studies further demonstrate the unique biological importance of MMP-14, as MMP-14-deficient mice develop severe craniofacial abnormalities, osteopenia, fibrosis, dwarfism, and impaired tissue homeostasis, highlighting functions that are not fully compensated by other MMP family members^[5][1]. Compared with related membrane-type MMP isoforms, MMP-14 is the best-characterized transmembrane collagenase and is distinguished by its potent pericellular collagenolytic activity, essential role in proMMP-2 activation, and ability to drive invasion within collagen-rich matrices^[5][1]. For experimental applications, MMP-14 is widely used as a mechanistic target for studying ECM remodeling, tumor invasion, angiogenesis, and protease-dependent signaling pathways, and selective inhibition of MMP-14 remains an active area of therapeutic research^[5][3].